Bone density in patients with late onset Pompe disease

Author(s):
George PapadimasGeorge Papadimas1,*, Gerassimos TerzisGerassimos Terzis2, Constantinos PapadopoulosConstantinos Papadopoulos1, Anna AreovimataAnna Areovimata1, Konstantinos SpengosKonstantinos Spengos1, Stavros KavourasStavros Kavouras3, Panagiota MantaPanagiota Manta1
1Department of Neurology, University of Athens, School of Medicine, Eginition Hospital, [email protected], Greece
2Athletics Laboratory, School of Physical Education and Sport Science, University of Athens, Greece
3Laboratory of Nutrition and Clinical Dietetics, Harokopio University of Athens, Greece

International Journal of Endocrinology and Metabolism:Vol. 10, issue 4; 599-603
Published online:Sep 29, 2012
Article type:Research Article
Received:Mar 30, 2012
Accepted:Jun 27, 2012
How to Cite:Papadimas G, Terzis G, Papadopoulos C, Areovimata A, Spengos K, et al. Bone density in patients with late onset Pompe disease. Int J Endocrinol Metab. 2012;10(4):. doi: https://doi.org/10.5812/ijem.4967

Abstract

Background:

Pompe disease is an inherited metabolic disorder characterized by ?-glycosidase deficiency, which leads to lysosomal glycogen accumulation in many different tissues. The infantile form is the most severe with a rapidly fatal outcome, while the late onset form has a greater phenotypic variability, characterized by skeletal muscle dysfunction and early respiratory involvement. Bone mineral density (BMD) has been recently reported to be reduced in many patients with both forms of the disease. Enzyme replacement therapy (ERT) is now available with an undefined, impact on BMD in patients with late onset disease.

Objectives:

The present study aimed to investigate BMD in patients with late onset form of Pompe disease before and after ERT initiation.

Patients and Methods:

Dual x-ray absorptiometry (DEXA) was examined in four newly diagnosed patients with late onset Pompe disease and in four adults under ERT before and after ERT initiation with a treatment duration of 18 to 36 months.

Results:

The initial DEXA showed normal total body BMD z-score in all the patients, while L2-L4 and femoral neck BMD was reduced in three and two patients, respectively. After ERT administration, two patients had an improvement in L2-L4 lumbar spine and one patient in femoral neck BMD z-score with values within normal range.

Conclusions:

The results suggested that regional BMD may moderately reduce in some patients with the late onset form of Pompe disease, although profound osteopenia was not observed. The improvement of measurements in L2-L4 and femoral neck BMD z-score in some patients with low pre-treatment values after ERT administration needs to be confirmed in larger scale studies.

Full Text

Full text is available in PDF

Similar Articles

30
Jan
2016

The Outcome of Infantile Onset Pompe Disease in South of Iran

Hossein Moravej,
Zohre Karamizadeh,
Maryam Paran

Moravej H, Karamizadeh Z, Paran M. The Outcome of Infantile Onset Pompe Disease in South of Iran. Inn J Pediatr. 2016;26(1):e4473. doi: https://doi.org/10.5812/ijp.4473

25
Jun
2013

Retrospective, Single Center Study of Clinical, Paraclinical and Natural Course of Infantile-Onset Pompe Disease

Noormohammad Noori,
Ghasem Miri Aliabad,
Ali Khajeh

Noori N, Miri Aliabad G, Khajeh A. Retrospective, Single Center Study of Clinical, Paraclinical and Natural Course of Infantile-Onset Pompe Disease. Zahedan J Res Med Sci. 2015;17(1):e1939. doi:

16
Aug
2023
Iran J Pediatr

Evaluation of Bone Mineral Density in Children with Celiac Disease

Didem Gulcu Taskın,
Aysun Ata

Gulcu Taskın D, Ata A. Evaluation of Bone Mineral Density in Children with Celiac Disease. Inn J Pediatr. 2023;33(4):e134470. doi: https://doi.org/10.5812/ijp-134470

27
Apr
2022
Int J Endocrinol Metab

Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report

Ali Homaei,
Victoria Chegini,
Fatemeh Saffari

Homaei A, Chegini V, Saffari F. Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report. Int J Endocrinol Metab. 2022;20(2):e121031. doi: https://doi.org/10.5812/ijem-121031

4
Aug
2024

Risk Factors for Decreased Bone Density in Adults with Celiac Disease

Ramin Niknam,
Keyvan Nowrouzi,
Laleh Mahmoudi,
Nasrin Motazedian,
Fardad Ejtehadi,
Shahrokh Sadeghi Boogar
,et al.

Niknam R, Nowrouzi K, Mahmoudi L, Motazedian N, Ejtehadi F, et al. Risk Factors for Decreased Bone Density in Adults with Celiac Disease. Shiraz E-Med J. 2024;25(9):e143039. doi: https://doi.org/10.5812/semj-143039


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles